The purpose of this study was to compare tacrolimus and hydrocortisone's ability to lower the inflammatory markers (TARC, CTACK, TSLP, and E‐selectin) that are often high in AD patients that has not been previously compared in investigations. This evidence concerns the gene CCL27 and Alzheimer disease.